Ryusuke Shodo
Department Of Otolaryngology Head And Neck Surgery, 1-757 Asahi Machi
Chuo, 9518510, Japan
Chuo, 9518510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Feasibility and preliminary effects of combined exercise and nutritional intervention on muscle mass preservation during chemoradiotherapy for head and neck cancer: a prospective study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 01, 2025
Concurrent chemoradiotherapy with docetaxel, cisplatin, and fluorouracil for patients with advanced external auditory canal squamous cell carcinoma: comparison with cisplatin-based concurrent chemoradiotherapy.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: May 02, 2025
Online video training for managing postoperative neck hemorrhage.
Journal: Auris, nasus, larynx
Published: March 16, 2025
The impact of detecting and autotransplanting parathyroid gland with near-infrared imaging during total laryngectomy with total thyroidectomy.
Journal: Auris, nasus, larynx
Published: February 19, 2025
Oropharyngeal candidiasis during radiotherapy for head and neck cancer: an observational study on prevalence, pain, and risk factors.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: February 10, 2025
Geriatric-8 as a Predictor of Delirium and Postoperative Complication in Older Head and Neck Cancer.
Geriatric-8 as a Predictor of Delirium and Postoperative Complication in Older Head and Neck Cancer.
Journal: The Laryngoscope
Published: February 06, 2025
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data.
Journal: International journal of clinical oncology
Published: January 04, 2025
PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumab.
Journal: Scientific reports
Published: April 18, 2024
Last Updated: 09/26/2026